AFMD Price Targets and Analyst Ratings NASDAQ:AFMD
AFMD Forecast. What You Should Know.
AFMD Historical Ratings and Targets
About Affimed N.V.
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.